Download MendeleyAllosteric competition and inhibition in AMPA receptors.
Hale, W.D., Montano Romero, A., Gonzalez, C.U., Jayaraman, V., Lau, A.Y., Huganir, R.L., Twomey, E.C.(2024) Nat Struct Mol Biol 31: 1669-1679
- PubMed: 38834914 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/s41594-024-01328-0
- Primary Citation Related Structures:
8VJ6, 8VJ7 - PubMed Abstract:
Excitatory neurotransmission is principally mediated by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-subtype ionotropic glutamate receptors (AMPARs). Negative allosteric modulators are therapeutic candidates that inhibit AMPAR activation and can compete with positive modulators to control AMPAR function through unresolved mechanisms. Here we show that allosteric inhibition pushes AMPARs into a distinct state that prevents both activation and positive allosteric modulation. We used cryo-electron microscopy to capture AMPARs bound to glutamate, while a negative allosteric modulator, GYKI-52466, and positive allosteric modulator, cyclothiazide, compete for control of the AMPARs. GYKI-52466 binds in the ion channel collar and inhibits AMPARs by decoupling the ligand-binding domains from the ion channel. The rearrangement of the ligand-binding domains ruptures the cyclothiazide site, preventing positive modulation. Our data provide a framework for understanding allostery of AMPARs and for rational design of therapeutics targeting AMPARs in neurological diseases.
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Organizational Affiliation:
